Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
As an international supplement brand under an Australian publicly listed company, VitaHealth has been delivering science-backed and innovative formulations since 1947
Its goal is to provide accessible, effective, and medically supervised GLP-1 therapy that integrates seamlessly into modern lifestyles
Since the first GLP-1 agonist was approved in 2005, a succession of new compounds has hit the market every few years
Media coverage and celebrity adoption accelerated public awareness, though it also led to off-label use and supply chain stress that affected patients with genuine medical need
Precision genetic testing can identify these predispositions before starting therapy, allowing clinicians to customize starting doses and escalation schedules
It also inhibits glucagon, which is a hormone that increases blood sugar
